Open access journal of the Ferrata-Storti Foundation, a non-profit organization

Open access journal of the Ferrata-Storti Foundation, a non-profit organization

Most downloaded 2023 papers

Reviews

The clinical impact of the molecular landscape of acute myeloid leukemia.

Kayser and Levis.

https://doi.org/10.3324/haematol.2022.280801

Leukemic stem cells and therapy resistance in acute myeloid leukemia.

Stelmach and Trumpp.

https://doi.org/10.3324/haematol.2022.280800

Prevention and management of secondary central nervous system lymphoma.

Bobillo et al.

https://doi.org/10.3324/haematol.2022.281457

Aspirin in essential thrombocythemia. For whom? What formulation? What regimen?

Cattaneo.

https://doi.org/10.3324/haematol.2022.281388

Original articles

Allogeneic transplant following CAR T-cell therapy for large B-cell lymphoma.

Zurko et al.

https://doi.org/10.3324/haematol.2022.281242

Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphoma.

Kwon et al.

https://doi.org/10.3324/haematol.2022.280805

COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey.

Marchesi et al.

https://doi.org/10.3324/haematol.2022.280847

Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learning.

Eckardt et al.

https://doi.org/10.3324/haematol.2021.280027

Letters to the Editor

Axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma patients in complete metabolic response.

Jallouk et al.

https://doi.org/10.3324/haematol.2022.281954

Treatment patterns and clinical outcomes of asciminib in a real-world multiresistant chronic myeloid leukemia patient population.

Kockerols et al.

https://doi.org/10.3324/haematol.2022.281386

What about you?

Tell us your interest and get all the new contents of haematologica in advance.